Cargando…
Flare of myasthenia gravis induced by COVID-19 vaccines
Autores principales: | Ishizuchi, Kei, Takizawa, Tsubasa, Sekiguchi, Koji, Motegi, Haruhiko, Oyama, Munenori, Nakahara, Jin, Suzuki, Shigeaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906005/ https://www.ncbi.nlm.nih.gov/pubmed/35290838 http://dx.doi.org/10.1016/j.jns.2022.120225 |
Ejemplares similares
-
Anemia in female patients with myasthenia gravis
por: Sekiguchi, Koji, et al.
Publicado: (2022) -
New onset of myasthenia gravis after intravesical Bacillus Calmette-Guerin: A case report and literature review
por: Takizawa, Tsubasa, et al.
Publicado: (2017) -
Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis
por: Oyama, Munenori, et al.
Publicado: (2020) -
Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011) -
Incidence of headache after COVID-19 vaccination in patients with history of headache: A cross-sectional study
por: Sekiguchi, Koji, et al.
Publicado: (2021)